Subscribe

Caroline Helwick

Authored Articles

Recent Surveys Highlight Ongoing Challenges for Oncology Practices
Caroline Helwick
November 2013, Vol 4, No 9
Read Article
Patient Assistance Programs
Caroline Helwick
October 2013, Vol 4, No 8
Read Article
Addressing Medication Nonadherence: A Patient–Provider Perspective
Caroline Helwick
October 2013, Vol 4, No 8
Read Article
Contracting in the Current Oncology Landscape
Caroline Helwick
October 2013, Vol 4, No 8
Read Article
Seeking Value in Oncology Care
Caroline Helwick
Value in Oncology
October 2013, Vol 4, No 8
Read Article
Community Oncology Practices Trying to Keep Afloat
Caroline Helwick
Community Oncology
October 2013, Vol 4, No 8
Read Article
Growing Pressures on Oncolytics to Demonstrate Value
Caroline Helwick
October 2013, Vol 4, No 8
Read Article
Implications of the Healthcare Exchanges for Oncology
Caroline Helwick
September 2013, Vol 4, No 7
Read Article
Bracing for Change in Healthcare Coverage with Medicaid Expansion: What This Means for Cancer Care Delivery
Caroline Helwick
September 2013, Vol 4, No 7
Read Article
Defining the Role of Government in Future Oncology Care
Caroline Helwick
September 2013, Vol 4, No 7
Read Article
NCCN/National Business Group on Health Collaboration Produces Guide for Employers
Caroline Helwick
September 2013, Vol 4, No 7
Read Article
Routine Surveillance CT Costly, Unnecessary in Lymphoma in Remission
Caroline Helwick
Economics & Value, Economics of Cancer Care
September 2013, Vol 4, No 7
Read Article
Quality Measures, Pricing, and Policy Challenges in the Oncology Landscape
Caroline Helwick
Economics & Value, Economics of Cancer Care
September 2013, Vol 4, No 7
Read Article
Balancing Cost and Quality in Oncology
Caroline Helwick
Economics & Value, Economics of Cancer Care
September 2013, Vol 4, No 7
Read Article
Patient Navigators Enhance Colonoscopy Screening Rates and Save Money in the Long Run
Caroline Helwick
Patient Navigation, Policies & Guidelines
July 2013, Vol 4, No 6
Read Article
Healthcare Reform and End-of-Life Care Myths versus Reality
Caroline Helwick
End-of-Life Care, Policies & Guidelines
July 2013, Vol 4, No 6
Read Article
A PBM Perspective on Biosimilars
Caroline Helwick
Biosimilars
July 2013, Vol 4, No 6
Read Article
Payers Must Step Up Their Utilization Management Programs
Caroline Helwick
July 2013, Vol 4, No 6
Read Article
CVS Caremark Value Proposition for Oncology Pharmacy
Caroline Helwick
July 2013, Vol 4, No 6
Read Article
Adenoma Detection Rates in Colonoscopy: The Higher the Better
Caroline Helwick
Colorectal Cancer, Personalized Medicine
July 2013, Vol 4, No 6
Read Article
Assessing the Value of New, Costly Radiation Therapies in Older Patients with Breast Cancer
Caroline Helwick
Economics & Value, Economics of Cancer Care
July 2013, Vol 4, No 6
Read Article
Can We Afford to Make Progress in Cancer Care? The Economics of Drug Development
Caroline Helwick
Economics & Value, Economics of Cancer Care
July 2013, Vol 4, No 6
Read Article
How Employers Are Adapting to the New Landscape in Healthcare
Caroline Helwick
July 2013, Vol 4, No 6
Read Article
Cancer Rehabilitation: The Next Frontier in the Care Continuum
Caroline Helwick
Cancer Rehabilitation
July 2013, Vol 4, No 6
Read Article
Off-Label Drug Use in Oncology Accounts for 18% of Spending
Caroline Helwick
Economics & Value, Economics of Cancer Care
June 2013, Vol 4, No 5
Read Article
FDA Expected to Approve Surrogate End Point for Neoadjuvant Breast Cancer Trials
Caroline Helwick
ASCO Annual Meeting, ASCO
June 2013, Vol 4, No 5
Read Article
The Cost of Cancer Care: We Must Incorporate Value and Quality of Life into the Mix
Caroline Helwick
June 2013, Vol 4, No 5
Read Article
Genomic Sequencing Assay Potentially a Game Changer
Caroline Helwick
June 2013, Vol 4, No 5
Read Article
Patient-Centered Oncology Medical Home in New Mexico Demonstrating Value
Caroline Helwick
June 2013, Vol 4, No 5
Read Article
Health IT Facilitates Patient Engagement Across Many Settings
Caroline Helwick
Practice Management, Value Peer-spectives
May 2013, Vol 4, No 4
Read Article
Cancer Support Program Documents Savings
Caroline Helwick
Economics & Value, Economics of Cancer Care
May 2013, Vol 4, No 4
Read Article
Aetna’s Value-Based Process Improvement for the Survival of Community Oncology
Caroline Helwick
Economics & Value, Value-Based Care
May 2013, Vol 4, No 4
Read Article
WellPoint’s Perspective on Value-Based Cancer Care for Today and Tomorrow
Caroline Helwick
Economics & Value, Value-Based Care
May 2013, Vol 4, No 4
Read Article
ASCO Urging Oncologists to Consider Value in Patient Care
Caroline Helwick
Value in Oncology
May 2013, Vol 4, No 4
Read Article
For Florida Congress­woman with a History of Cancer, Genetic Patent Case Is Personal
Caroline Helwick
AVBCC Annual Conference
May 2013, Vol 4, No 4
Read Article
AVBCC Third Annual Conference: Stakeholders Unite Around Common Challenges
Caroline Helwick
AVBCC Annual Conference
May 2013, Vol 4, No 4
Read Article
Ochsner CEO Calls for Adding Value in Healthcare
Caroline Helwick
Health Policy, Policies & Guidelines
March 2013, Vol 4, No 3
Read Article
Evidence Still Cloudy for Anticancer Effects with Metformin
Caroline Helwick
Clinical Research, Personalized Medicine
March 2013, Highlights
Read Article
More Evidence Links Vitamin D Deficiency to Worse Outcomes in Breast Cancer
Caroline Helwick
Clinical Research, Personalized Medicine
March 2013, Highlights
Read Article
Venlafaxine Lowers Endoxifen Levels, Reduces Tamoxifen Effectiveness
Caroline Helwick
Clinical Research, Personalized Medicine
March 2013, Highlights
Read Article
HDAC Inhibitor plus PARP Inhibitor or Cisplatin Induce Apoptosis of Triple-Negative Breast Cancer Cells
Caroline Helwick
Breast Cancer, Personalized Medicine, Solid Tumors
March 2013, Highlights
Read Article
Benefit of Higher Doses of Fulvestrant Confirmed
Caroline Helwick
Hormone Therapy, Personalized Medicine
March 2013, Highlights
Read Article
Black Women Less Likely to Receive Sentinel Node Dissection Therapy
Caroline Helwick
Sentinel Node Management, Personalized Medicine
March 2013, Highlights
Read Article
Molecular Profiling in Early Invasive Breast Cancer
Caroline Helwick
Prognostic Tests, Personalized Medicine
March 2013, Highlights
Read Article
Eribulin Plus Trastuzumab an Effective Combination
Caroline Helwick
Breast Cancer, Personalized Medicine, Solid Tumors
March 2013, Highlights
Read Article
HER2 Mutations May Become New Treatment Targets
Caroline Helwick
Breast Cancer, Personalized Medicine, Solid Tumors
March 2013, Highlights
Read Article
One Year of Trastuzumab Remains the Standard of Care
Caroline Helwick
Breast Cancer, Personalized Medicine, Solid Tumors
March 2013, Highlights
Read Article
“Chemo Brain” May Be Present Before Chemotherapy
Caroline Helwick
Chemotherapy, Personalized Medicine
March 2013, Highlights
Read Article
Gabriel N. Hortobagyi, MD, Delivers the William I. McGuire Memorial Lecture
Caroline Helwick
Chemotherapy, Personalized Medicine
March 2013, Highlights
Read Article
Gene-Expression Profiling May Help Select Best Drugs for Pancreatic Cancer
Caroline Helwick
GI Cancers Symposium
February 2013, Vol 4, No 2
Read Article
Drugs to Reduce Breast Cancer Risk Are Rarely Used Show Data from Geisinger Health System
Caroline Helwick
Breast Cancer, Personalized Medicine, Solid Tumors
February 2013, Vol 4, No 2
Read Article
Second-Line Rituximab Maintenance for Follicular Lymphoma Cost-Effective
Caroline Helwick
ASH 2013 Annual Meeting
February 2013, Vol 4, No 2
Read Article
Most Women Not Willing to Pay for Genetic Breast Cancer Testing
Caroline Helwick
Economics & Value, Health Economics
February 2013, Vol 4, No 2
Read Article
Costs of Second-Line Metastatic Colorectal Cancer Treatments Compared
Caroline Helwick
Economics & Value, Health Economics
February 2013, Vol 4, No 2
Read Article
Mayo Clinic Researchers Propose Screening Algorithm for HER2 in Patients with Esophageal Cancer
Caroline Helwick
GI Cancers Symposium
February 2013, Vol 4, No 2
Read Article
In Patients with Colon Cancer, Genomic Classifiers Aid in Prognosis
Caroline Helwick
GI Cancers Symposium
February 2013, Vol 4, No 2
Read Article
Real-Time Performance Tracking Improves Patient Care at 64 Cancer Centers
Caroline Helwick
ASCO’s 1st Quality Care Symposium, ASCO
January 2013, Vol 4, No 1
Read Article
Multidisciplinary Palliative Care Team at Johns Hopkins Achieves Reduction in ICU Utilization, Cost
Caroline Helwick
ASCO’s 1st Quality Care Symposium, ASCO
January 2013, Vol 4, No 1
Read Article
Azacitidine Reduces Transfusions and Costs for Patients with High-Risk MDS
Caroline Helwick
Health Economics
January 2013, Vol 4, No 1
Read Article
Applying Whole-Genome Analysis to Treatment Decisions in Daily Practice
Caroline Helwick
Personalized Medicine
January 2013, Vol 4, No 1
Read Article
Rivaroxaban More Cost-Effective than Warfarin in the Prevention of Recurrent VTE
Caroline Helwick
ASH 2013 Annual Meeting
January 2013, Vol 4, No 1
Read Article
New Data Demonstrate Overall Survival Benefit with Pomalidomide in Advanced Myeloma
Caroline Helwick
ASH 2013 Annual Meeting
January 2013, Vol 4, No 1
Read Article
Oral Proteasome Inhibitor MLN9708 a News Maker at ASH 2012
Caroline Helwick
ASH 2013 Annual Meeting
January 2013, Vol 4, No 1
Read Article
Rasburicase Cost-Effective for Tumor Lysis Syndrome
Caroline Helwick
ASH 2013 Annual Meeting
January 2013, Vol 4, No 1
Read Article
Quality Oncology Practice Initiative Shows Strong Improvement in Some Care Measures
Caroline Helwick
ASCO’s 1st Quality Care Symposium, ASCO
January 2013, Vol 4, No 1
Read Article
Cost of Screening Mammography Varies by Strategy
Caroline Helwick
Health Economics
January 2013, Vol 4, No 1
Read Article
Cost-Effectiveness Comparison of First-Line Therapies for Advanced Non–Small-Cell Lung Cancer
Caroline Helwick
ESMO 2012 Conference, ESMO
November 2012, Vol 3, No 8
Read Article
To Many Employers, Specialty Pharmacy Is a Vague Concept
Caroline Helwick
AVBCC Annual Conference, Specialty Pharmacy
November 2012, Vol 3, No 8
Read Article
Employers’ Challenge: Cut Healthcare Costs Without Limiting Employees’ Benefits
Caroline Helwick
AVBCC Annual Conference
November 2012, Vol 3, No 8
Read Article
Some Staging Studies Not Beneficial in Early Breast Cancer Work-Up
Caroline Helwick
Breast Cancer Symposium
November 2012, Vol 3, No 8
Read Article
The Missing Perspective in Personalized Cancer Care
Caroline Helwick
Personalized Medicine
November 2012, Vol 3, No 8
Read Article
Cumulative Financial Impact of Skeletal-Related Events on Patients with Breast Cancer Is Significant
Caroline Helwick
Economics & Value, Economics of Cancer Care
November 2012, Vol 3, No 8
Read Article
Delta Air Lines’ Approach to Patient Care: High-Performance Cancer Networks
Caroline Helwick
AVBCC Annual Conference
November 2012, Vol 3, No 8
Read Article
Companion Drug Testing Is Becoming Critical to Pharmacy Benefits Management
Caroline Helwick
AVBCC Annual Conference
October 2012, Vol 3, No 7
Read Article
Health Plans Need Policies for Dealing with Off-Label Drug Use
Caroline Helwick
AVBCC Annual Conference
October 2012, Vol 3, No 7
Read Article
An Underappreciated Cause of Cancer Death: Disparities in Treatment
Caroline Helwick
Breast Cancer Symposium
October 2012, Vol 3, No 7
Read Article
Is Personalized Cancer Care Affordable?
Caroline Helwick
Personalized Medicine
October 2012, Vol 3, No 7
Read Article
ESMO Theme: Personalized (“Precision”) Oncology Care Marches Forward
Caroline Helwick
Personalized Medicine
October 2012, Vol 3, No 7
Read Article
Head-to-Head Comparison: Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
Caroline Helwick
ESMO 2012 Conference, ESMO
October 2012, Vol 3, No 7
Read Article
Indirect Costs of Metastatic Breast Cancer Are Substantial
Caroline Helwick
Breast Cancer Symposium
October 2012, Vol 3, No 7
Read Article
Many Emerging Biomarkers, but Few Are Clinically Applicable
Caroline Helwick
AVBCC Annual Conference
October 2012, Vol 3, No 7
Read Article
Continuation of Bevacizumab Beyond Progression Improves Outcome in Patients with Metastatic Colorectal Cancer
Caroline Helwick
ESMO 2012 Conference, ESMO
October 2012, Vol 3, No 7
Read Article
In Colorectal Cancer, Treatment Efficacy Is High Among the Elderly
Caroline Helwick
AMCP Annual Meeting
July 2012, Vol 3, No 5
Read Article
Vemurafenib Does Not Impact Health Plan Budget
Caroline Helwick
AMCP Annual Meeting
July 2012, Vol 3, No 5
Read Article
Pathways Offer Providers a True Value Proposition
Caroline Helwick
AVBCC Annual Conference
July 2012, Vol 3, No 5
Read Article
Tough Times for Small Oncology Practices
Caroline Helwick
AVBCC Annual Conference
July 2012, Vol 3, No 5
Read Article
Involving the Patient in End-of-Life Care Decisions: Aetna’s Oncology Strategy
Caroline Helwick
AVBCC Annual Conference, End-of-Life Care, Policies & Guidelines
July 2012, Vol 3, No 5
Read Article
Evidence-Based Guidelines/Pathways Critical for Value-Based Benefit Design in Oncology
Caroline Helwick
AVBCC Annual Conference
July 2012, Vol 3, No 5
Read Article
Chemotherapy-Related Toxicity Adds to Economic Burden in Metastatic Breast Cancer
Caroline Helwick
ASCO Annual Meeting, ASCO
July 2012, Vol 3, No 5
Read Article
Endocrine Therapy Substantially Underutilized Among Low-Income Patients with Breast Cancer
Caroline Helwick
ASCO Annual Meeting, ASCO
July 2012, Vol 3, No 5
Read Article
CareFirst Oncology Management Program Aims to Manage the “Entire Oncology Patient”
Caroline Helwick
AVBCC Annual Conference
June 2012, Vol 3, No 4
Read Article
Personalized Medicine Empowers Treatment Decisions
Caroline Helwick
AVBCC Annual Conference
June 2012, Vol 3, No 4
Read Article
The Value of Level I Pathways at US Oncology
Caroline Helwick
AVBCC Annual Conference
June 2012, Vol 3, No 4
Read Article
“Precision Medicine” the Theme of ASCO 2012
Caroline Helwick
ASCO Annual Meeting, ASCO
June 2012, Vol 3, No 4
Read Article
Community Oncology in Crisis
Caroline Helwick
AVBCC Annual Conference
May 2012, Vol 3, No 3
Read Article
WellPoint: Aligning Reimbursement with Value-Based, Patient-Centered Outcomes
Caroline Helwick
AVBCC Annual Conference
May 2012, Vol 3, No 3
Read Article
Seeking Value in Oncology Is Like Chasing an Elephant
Caroline Helwick
AVBCC Annual Conference
May 2012, Vol 3, No 3
Read Article
Payer Trends in Oncology: Challenges and Solutions
Caroline Helwick
AVBCC Annual Conference
May 2012, Vol 3, No 3
Read Article
Everolimus Has Minimal Economic Impact on Treatment of Pancreatic NETs
Caroline Helwick
Gasterol Intestinal Symposium
March 2012, Vol 3, No 2
Read Article
AMA Delegates and Oncologists Balk at ICD-10 Implementation
Caroline Helwick
Health Policy, Policies & Guidelines
March 2012, Vol 3, No 2
Read Article
For Metastatic Breast Cancer, Nab-Paclitaxel Requires Less Growth Factor Support
Caroline Helwick
Breast Cancer, Personalized Medicine, Solid Tumors
March 2012, Vol 3, No 2
Read Article
Dose-Dense Chemotherapy plus Growth Factors in Elderly ER-Positive Patients Unnecessary, Costly
Caroline Helwick
Breast Cancer, Personalized Medicine, Solid Tumors
March 2012, Vol 3, No 2
Read Article
For Pancreatic Cancer, Neoadjuvant Chemoradiation Cost-Effective Compared with Surgery First
Caroline Helwick
Gasterol Intestinal Symposium
March 2012, Vol 3, No 2
Read Article
Economic Burden of Febrile Neutropenia in NHL Exceeds $11,000 per Episode
Caroline Helwick
ASH Highlights, ASH 2011 Annual Meeting
March 2012, Vol 3, No 2
Read Article
Novel Oral B-Cell Receptor Inhibitor Very Effective in Chronic Lymphocytic Leukemia
Caroline Helwick
ASH Highlights, ASH 2011 Annual Meeting
March 2012, Vol 3, No 2
Read Article
Confusion Still Surrounds Prophylaxis for Venous Thromboembolism
Caroline Helwick
ASH Highlights, ASH 2011 Annual Meeting
March 2012, Vol 3, No 2
Read Article
High-Risk Myelodysplastic Syndrome: First-Line Treatment Choices Often Not Supported by Evidence
Caroline Helwick
ASH Highlights, ASH 2011 Annual Meeting
March 2012, Vol 3, No 2
Read Article
Physician-Led Approach Can Cut Unnecessary Testing in Prostate Cancer
Caroline Helwick
Personalized Medicine, Prostate Cancer, Solid Tumors
February 2012, Vol 3, No 1
Read Article
Direct-to-Consumer Genetic Testing: Concerns Trump Benefits at This Point
Caroline Helwick
Health Policy, Policies & Guidelines
February 2012, Vol 3, No 1
Read Article
VTE Prophylaxis during Chemotherapy Cost-Effective
Caroline Helwick
ASH Highlights, ASH 2011 Annual Meeting
February 2012, Vol 3, No 1
Read Article
Next-Generation Proteasome Inhibitors Cause Less Peripheral Neuropathy
Caroline Helwick
ASH Highlights, ASH 2011 Annual Meeting
February 2012, Vol 3, No 1
Read Article
A Large Study Sheds Light on the Cost of Managing NHL
Caroline Helwick
ASH Highlights, ASH 2011 Annual Meeting
February 2012, Vol 3, No 1
Read Article
Guidelines for Molecular/Cytogenetic Tests Can Eliminate Overordering, Reduce Costs
Caroline Helwick
ASH Highlights, ASH 2011 Annual Meeting
February 2012, Vol 3, No 1
Read Article
Regorafenib Extends Survival in Advanced CRC
Caroline Helwick
GI Cancers Symposium
February 2012, Vol 3, No 1
Read Article
Future Directions in Myeloma
Caroline Helwick
ASH 2011 Annual Meeting
February 2012, Vol 3, No 1
Read Article
The Promise of Molecular Profiling
Caroline Helwick
Economics & Value, Value-Based Care, VBCC Perspectives
February 2012, Vol 3, No 1
Read Article
The Cost of Cancer Care: How Can We Spend Better?
Caroline Helwick
Breast Cancer, Personalized Medicine, Solid Tumors
February 2012, Vol 3, No 1
Read Article
Economic Implications of Biosimilars in Oncology
Caroline Helwick
Drug Updates, Biosimilars
December 2011, Vol 2, No 7
Read Article
AMA Calls for More Transparency in Patient Navigation Programs
Caroline Helwick
Patient Navigation, Policies & Guidelines
December 2011, Vol 2, No 7
Read Article
Young Patients Are Served Equally Well by Lumpectomy or Mastectomy
Caroline Helwick
ASCO Breast Cancer Symposium
December 2011, Vol 2, No 7
Read Article
Delivering Affordable, Evidence-Based Cancer Care in High-Income Countries
Caroline Helwick
ESMO 2011 Conference, ESMO
December 2011, Vol 2, No 7
Read Article
Thromboembolism after Chemotherapy Raises Healthcare Costs about 30%
Caroline Helwick
ESMO 2011 Conference, ESMO
December 2011, Vol 2, No 7
Read Article
Medical Staff Members Spend Many Hours Dealing with Insurance Companies
Caroline Helwick
Health Policy, Policies & Guidelines
December 2011, Vol 2, No 7
Read Article
SWOG: Two Hormonal Agents Extend Survival over Anastrozole Alone in Metastatic Breast Cancer
Caroline Helwick
CTRC-AACR SABCS Annual Meeting
December 2011, Vol 2, No 7
Read Article
New Prognostic Tool to Guide Treatment of Ductal Carcinoma In Situ
Caroline Helwick
CTRC-AACR SABCS Annual Meeting
December 2011, Vol 2, No 7
Read Article
Adding Everolimus to Exemestane Significantly Prolongs Remission in Patients with Breast Cancer
Caroline Helwick
CTRC-AACR SABCS Annual Meeting
December 2011, Vol 2, No 7
Read Article
Dual HER2 Blockade with Pertuzumab Substantially Delays Disease Progression
Caroline Helwick
CTRC-AACR SABCS Annual Meeting
December 2011, Vol 2, No 7
Read Article
Survivorship Programs an Emerging Need, But Are They Cost-Effective?
Caroline Helwick
Policies & Guidelines, Survivorship Care
October 2011, Vol 2, No 6
Read Article
Targeted Radiation Therapy Gaining Momentum
Caroline Helwick
ASCO Breast Cancer Symposium
October 2011, Vol 2, No 6
Read Article
New T-DM1 Reduces Disease Progression by 40% in Advanced Breast Cancer, with Low Toxicity
Caroline Helwick
October 2011, Vol 2, No 6
Read Article
Everolimus-Exemestane Combination Prolongs Remission by 4 Months in Metastatic Breast Cancer
Caroline Helwick
ESMO, ESMO 2011 Conference
October 2011, Vol 2, No 6
Read Article
Positive Data Continue to Accrue for Crizotinib in ALK-Positive NSCLC
Caroline Helwick
ESMO, ESMO 2011 Conference
October 2011, Vol 2, No 6
Read Article
Value of Bevacizumab in Ovarian Cancer Got a Boost in a New Analysis
Caroline Helwick
ESMO, ESMO 2011 Conference
October 2011, Vol 2, No 6
Read Article
Pemetrexed Plus Bevacizumab Maintenance Keeps NSCLC at Bay Longer
Caroline Helwick
ESMO, ESMO 2011 Conference
October 2011, Vol 2, No 6
Read Article
New Bone-Targeting Compound Improves Survival in Metastatic Prostate Cancer
Caroline Helwick
ESMO, ESMO 2011 Conference
October 2011, Vol 2, No 6
Read Article
Therapy-Associated Complications Significantly Increase Cost of Cancer Care
Caroline Helwick
ESMO, ESMO 2011 Conference
October 2011, Vol 2, No 6
Read Article
Colonoscopy Overused in Medicare Recipients, Adding Unnecessary Expenditures
Caroline Helwick
Cancer Care, Personalized Medicine
August 2011, Vol 2, No 5
Read Article
Screening for Pancreatic Cancer Is Effective, Has Value— at Least in High-Risk Individuals
Caroline Helwick
Cancer Care, Personalized Medicine
August 2011, Vol 2, No 5
Read Article
Post-ASCO Survey: Oncologists’ and Payers’ Treatment and Coverage Decisions
Caroline Helwick
Economics & Value, Reimbursement
August 2011, Vol 2, No 5
Read Article
Dose-Monitoring, Split-Fill Programs Reduce Oral Chemotherapy Waste, Save Costs
Caroline Helwick
Oncology
August 2011, Vol 2, No 5
Read Article
Accountable Care Organizations: Implications for Cancer-Related Quality Care and Spending
Caroline Helwick
Health Policy, Policies & Guidelines
August 2011, Vol 2, No 5
Read Article
Comparing the Value of Denosumab versus Zoledronic Acid in Preventing Cancer-Related Skeletal Events
Caroline Helwick
ASCO Annual Meeting
August 2011, Vol 2, No 5
Read Article
Genome-Forward Medicine in Lung Cancer
Caroline Helwick
ASCO Annual Meeting
August 2011, Vol 2, No 5
Read Article
Patients with Cancer at Risk for Bankruptcy
Caroline Helwick
ASCO Annual Meeting
August 2011, Vol 2, No 5
Read Article
Post-ASCO Survey: Oncologists’ and Payers’ Treatment and Coverage Decisions
Caroline Helwick
Reimbursement
August 2011, Vol 2, No 5
Read Article
Significant Advances in Lung Cancer Highlighted at AACR
Caroline Helwick
AACR Annual Meeting
June 2011, Vol 2, No 3
Read Article
Sorafenib Active Third-Line in Refractory GIST
Caroline Helwick
Genitourinary Cancers Symposium
April 2011, Vol 2, No 2
Read Article
Future of Colorectal Cancer Therapy: Novel Targeted Pathways
Caroline Helwick
Colorectal Cancer, Genitourinary Cancers Symposium
April 2011, Vol 2, No 2
Read Article
Competing Tests for Colorectal Cancer Risk Recurrence
Caroline Helwick
Colorectal Cancer, Genitourinary Cancers Symposium
April 2011, Vol 2, No 2
Read Article
Some Biologics Fail in Early-Stage Tumors
Caroline Helwick
Colon Cancer, Solid Tumors
November/December 2010, Vol 1, No 6
Read Article
Cancer Drugs: NICE Rejects Costly Treatments
Caroline Helwick
Cancer Care, Personalized Medicine
November/December 2010, Vol 1, No 6
Read Article
High Cost to Managing Colorectal Cancer Toxicities
Caroline Helwick
ESMO 2010 Conference, ESMO
November/December 2010, Vol 1, No 6
Read Article
Contralateral Prophylactic Mastectomy Improves Survival, Is Cost-Effective in Some
Caroline Helwick
ASCO Breast Cancer Symposium
November/December 2010, Vol 1, No 6
Read Article

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

© Amplity Health. All Rights Reserved. Privacy Policy.